1. Zane C, Leali C, Airò P, De Panfilis G, Pinton PC. "High-dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol. 2001. 44:629–633.
Article
2. Plettenberg H, Stege H, Megahed M, Ruzicka T, Hosokawa Y, Tsuji T, et al. Ultraviolet A1 (340~400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 1999. 41:47–50.
Article
3. Carter J, Zug KA. Phototherapy for cutaneous T-cell lymphoma: online survey and literature review. J Am Acad Dermatol. 2009. 60:39–50.
Article
4. Breuckmann F, von Kobyletzki G, Avermaete A, Radenhausen M, Höxtermann S, Pieck C, et al. Mechanisms of apoptosis: UVA1-induced immediate and UVB-induced delayed apoptosis in human T cells in vitro. J Eur Acad Dermatol Venereol. 2003. 17:418–429.
Article
5. Weichenthal M, Schwarz T. Phototherapy: how does UV work? Photodermatol Photoimmunol Photomed. 2005. 21:260–266.
Article
6. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol. 1999. 112:3–12.
Article
7. Yamauchi R, Morita A, Yasuda Y, Grether-Beck S, Klotz LO, Tsuji T, et al. Different susceptibility of malignant versus nonmalignant human T cells toward ultraviolet A-1 radiation-induced apoptosis. J Invest Dermatol. 2004. 122:477–483.
Article
8. Von Kobyletzki G, Heine O, Stephan H, Pieck C, Stücker M, Hoffmann K, et al. UVA1 irradiation induces deoxyribonuclease dependent apoptosis in cutaneous T-cell lymphoma in vivo. Photodermatol Photoimmunol Photomed. 2000. 16:271–277.
9. Tuchinda C, Kerr HA, Taylor CR, Jacobe H, Bergamo BM, Elmets C, et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed. 2006. 22:247–253.
Article
10. Besaratinia A, Synold TW, Chen HH, Chang C, Xi B, Riggs AD, et al. DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc Natl Acad Sci U S A. 2005. 102:10058–10063.
Article